Floatz logo

Pyridoxal 5'-Phosphate

Diabetes Mellitus Type 2

MedicurePhase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

142 Active assets in the Diabetes Mellitus Type 2 cohort.

Asset / SponsorPhaseRating
Liraglutide
RenJi Hospital
Phase 4BBB
Semaglutide
Shanghai Jiao Tong University School of Medicine
Phase 4BBB
Exenatide
Vivani Medical, Inc
Phase 4BBB
Cotadutide
AstraZeneca
Phase 2BBB
Dapagliflozin
Bhavya Bhavya, MD
Phase 4BBB

View all 50 →

Same molecule, other indications

Pyridoxal 5'-Phosphate is also rated in:

hypertensive disorderDormant
CCC
Indicative ·
55 / 100
View asset →
tardive dyskinesiaDormant
CCC
Indicative ·
53 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →